GlassScriptPhysician profile
Amanda Lewis
NPI 1801997226
$2,319.39
in general payments reported to CMS, 2019-2025
17 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $283 · 2023: $896 · 2024: $768 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $968 · Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $968.30 |
| Food and Beverage | $845.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $618.21 | 2024 | Synchromedii |
| Relievant Medsystems, INC. | $548.93 | 2023 | Intracept |
| Abbvie INC. | $458.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $161.73 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Mylan Specialty L.P. | $96.34 | 2021-2023 | Yupelri |
| Pfizer INC. | $76.13 | 2023-2025 | |
| Alkermes, INC. | $68.14 | 2022-2023 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $61.49 | 2023-2025 | Ingrezza |
| Idorsia Pharmaceuticals US INC | $47.10 | 2023-2024 | Quviviq |
| Novo Nordisk INC | $34.88 | 2025 | Wegovy |
| Astellas Pharma US INC | $29.07 | 2023-2024 | Veozah, Myrbetriq |
| Stryker Corporation | $27.09 | 2025 | Mild Device Kit |
| Agile Therapeutics, INC. | $25.02 | 2021 | |
| Boston Scientific Corporation | $22.16 | 2021 | |
| Lilly USA, LLC | $16.79 | 2023 | Mounjaro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $16.08 | 2024 | Generator |
| Ironshore Pharmaceuticals INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.